<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tisi S</submitter><funding>Cancer Research UK</funding><funding>GRAIL Inc</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Wellcome Trust</funding><pagination>e001664</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10277548</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Pulmonary and extrapulmonary incidental findings are frequently identified on CT scans performed for lung cancer screening. Uncertainty regarding their clinical significance and how and when such findings should be reported back to clinicians and participants persists. We examined the prevalence of non-malignant incidental findings within a lung cancer screening cohort and investigated the morbidity and relevant risk factors associated with incidental findings. We quantified the primary and secondary care referrals generated by our protocol.&lt;h4>Methods&lt;/h4>The SUMMIT study (NCT03934866) is a prospective observational cohort study to examine the performance of delivering a low-dose CT (LDCT) screening service to a high-risk population. Spirometry, blood pressure, height/w</pubmed_abstract><journal>BMJ open respiratory research</journal><pubmed_title>Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort.</pubmed_title><pmcid>PMC10277548</pmcid><funding_grant_id>WT107963AIA</funding_grant_id><funding_grant_id>CTUQQR-DEC22/100009</funding_grant_id><funding_grant_id>EDDCPGM\100002</funding_grant_id><funding_grant_id>Not Applicable</funding_grant_id><funding_grant_id>28706</funding_grant_id><pubmed_authors>Patel A</pubmed_authors><pubmed_authors>Parry-Billings K</pubmed_authors><pubmed_authors>O'Shaughnessy T</pubmed_authors><pubmed_authors>Cotton A</pubmed_authors><pubmed_authors>Clark M</pubmed_authors><pubmed_authors>Janes S</pubmed_authors><pubmed_authors>Hanif Z</pubmed_authors><pubmed_authors>Miah M</pubmed_authors><pubmed_authors>Stefan E</pubmed_authors><pubmed_authors>Crossingham A</pubmed_authors><pubmed_authors>TaniaAnastasiadis AP</pubmed_authors><pubmed_authors>Taylor M</pubmed_authors><pubmed_authors>Teague J</pubmed_authors><pubmed_authors>Samson A</pubmed_authors><pubmed_authors>Verghese P</pubmed_authors><pubmed_authors>Jacob J</pubmed_authors><pubmed_authors>Patel U</pubmed_authors><pubmed_authors>Arancon D</pubmed_authors><pubmed_authors>Bhowmik A</pubmed_authors><pubmed_authors>Eng J</pubmed_authors><pubmed_authors>Sarpong R</pubmed_authors><pubmed_authors>Mehta S</pubmed_authors><pubmed_authors>Neville A</pubmed_authors><pubmed_authors>McEwen R</pubmed_authors><pubmed_authors>Mangera Z</pubmed_authors><pubmed_authors>Screaton N</pubmed_authors><pubmed_authors>Ellis S</pubmed_authors><pubmed_authors>Villanueva A</pubmed_authors><pubmed_authors>Gowers K</pubmed_authors><pubmed_authors>Airebamen J</pubmed_authors><pubmed_authors>Hackshaw A</pubmed_authors><pubmed_authors>Buchan T</pubmed_authors><pubmed_authors>Chan K</pubmed_authors><pubmed_authors>Hall H</pubmed_authors><pubmed_authors>Hacker AM</pubmed_authors><pubmed_authors>Quaife SL</pubmed_authors><pubmed_authors>Aziz T</pubmed_authors><pubmed_authors>Davies K</pubmed_authors><pubmed_authors>Janes SM</pubmed_authors><pubmed_authors>Nnorom S</pubmed_authors><pubmed_authors>Levermore C</pubmed_authors><pubmed_authors>Prendecki R</pubmed_authors><pubmed_authors>Phua K</pubmed_authors><pubmed_authors>Hurst JR</pubmed_authors><pubmed_authors>Ricketts WM</pubmed_authors><pubmed_authors>Dickson J</pubmed_authors><pubmed_authors>El-Emir E</pubmed_authors><pubmed_authors>Lock S</pubmed_authors><pubmed_authors>Gyertson K</pubmed_authors><pubmed_authors>Beech N</pubmed_authors><pubmed_authors>Horst C</pubmed_authors><pubmed_authors>Tisi S</pubmed_authors><pubmed_authors>Creamer A</pubmed_authors><pubmed_authors>Bhamani A</pubmed_authors><pubmed_authors>Bojang F</pubmed_authors><pubmed_authors>Kiconco H</pubmed_authors><pubmed_authors>Ovayolu D</pubmed_authors><pubmed_authors>Zylstra J</pubmed_authors><pubmed_authors>Rusius J</pubmed_authors><pubmed_authors>Banka R</pubmed_authors><pubmed_authors>Hare S</pubmed_authors><pubmed_authors>Cash C</pubmed_authors><pubmed_authors>Sayer C</pubmed_authors><pubmed_authors>Navani N</pubmed_authors><pubmed_authors>Mullin AM</pubmed_authors><pubmed_authors>Rowlands J</pubmed_authors><pubmed_authors>Murali E</pubmed_authors><pubmed_authors>Pervez H</pubmed_authors><pubmed_authors>Ife C</pubmed_authors><pubmed_authors>McKee J</pubmed_authors><pubmed_authors>Enes SP</pubmed_authors><pubmed_authors>Robbie H</pubmed_authors><pubmed_authors>Gallagher L</pubmed_authors><pubmed_authors>Hosein C</pubmed_authors><pubmed_authors>Robinson P</pubmed_authors><pubmed_authors>Quaife S</pubmed_authors><pubmed_authors>Nundlall N</pubmed_authors><pubmed_authors>Devaraj A</pubmed_authors><pubmed_authors>Creamer AW</pubmed_authors><pubmed_authors>Green L</pubmed_authors><pubmed_authors>Sennett K</pubmed_authors><pubmed_authors>Neville QA</pubmed_authors><pubmed_authors>Limani T</pubmed_authors><pubmed_authors>Dickson JL</pubmed_authors><pubmed_authors>Farrelly L</pubmed_authors><pubmed_authors>Ekeowa U</pubmed_authors><pubmed_authors>Bowyer V</pubmed_authors><pubmed_authors>SUMMIT Consortium</pubmed_authors><pubmed_authors>Callender T</pubmed_authors><pubmed_authors>Ruparel M</pubmed_authors><pubmed_authors>Hoque F</pubmed_authors><pubmed_authors>Edey A</pubmed_authors><pubmed_authors>McCabe J</pubmed_authors><pubmed_authors>Robinson G</pubmed_authors><pubmed_authors>Nair A</pubmed_authors><pubmed_authors>Suresh M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort.</name><description>&lt;h4>Background&lt;/h4>Pulmonary and extrapulmonary incidental findings are frequently identified on CT scans performed for lung cancer screening. Uncertainty regarding their clinical significance and how and when such findings should be reported back to clinicians and participants persists. We examined the prevalence of non-malignant incidental findings within a lung cancer screening cohort and investigated the morbidity and relevant risk factors associated with incidental findings. We quantified the primary and secondary care referrals generated by our protocol.&lt;h4>Methods&lt;/h4>The SUMMIT study (NCT03934866) is a prospective observational cohort study to examine the performance of delivering a low-dose CT (LDCT) screening service to a high-risk population. Spirometry, blood pressure, height/w</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2026-07-14T17:17:32.753Z</modification><creation>2026-06-21T03:12:39.643Z</creation></dates><accession>S-EPMC10277548</accession><cross_references><pubmed>37321665</pubmed><doi>10.1136/bmjresp-2023-001664</doi></cross_references></HashMap>